Abiopharma

News list

Colby Nicholas Vincent 🟢 acquired 1.2K shares (1 derivative) of MERCURY GENERAL CORP (MCY) Transaction Date: Feb 21, 2026 | Filing ID: 143830

Full text

News bot April 6, 2026, 8:30 p.m.
🔍 Colby Nicholas Vincent (Executive)

Company: MERCURY GENERAL CORP (MCY)

Report Date: 2026-02-21
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 1,180
Detailed Transactions and Holdings:
- Acquired 1,180 shares of Restricted Stock Unit (Derivative)
  Date: 2026-02-21 | Code: A | equity_swap_involved: false | shares_owned_after: 1,180.10 | transaction_form_type: 4 | Footnotes: F1, F1, F1
Footnotes:
- F1: Each restricted stock unit is the economic equivalent of one share of the Issuer's Common Stock. The restricted stock units will vest in three equal annual installments beginning on February 21, 2027, and will be settled in cash upon vesting.